netFormulary NHS
Pan Mersey
Area Prescribing Committee
 Formulary Chapter 9: Nutrition and blood - Full Section

Coronavirus guidance

Guidance to support primary care prescribers and pharmacists is available from the MLCSU Coronavirus guidance resource page. Links are provided to national resources and regional documents produced by MLCSU, RDTC, and SPS for use by Pan Mersey APC, LSCMMG, and GMMMG.

The list of resources will be updated as new material becomes available so please check back regularly for updates.

The Pan Mersey APC supports the use of COVID-specific guidance issued by NICE, and NHS England and NHS Improvement. During the COVID pandemic this will supersede any APC advice.

Nutrition and blood

Review date: July 2022

Non-formulary drugs: Any drug or formulation not listed in the formulary is deemed to be non-formulary.

Off-label use: Drugs are included in the formulary for their licensed indications – where inclusion of off-label use is considered to be included in the formulary this is specifically stated in the formulary entry for the drug N.B. also see Paediatrics note below.

Paediatrics: Drugs are included in the formulary for paediatric use for their BNF for Children recommended indications (indicated by symbol View childrens BNF) which may be off-label, unless otherwise stated. All drugs are deemed to have the same RAG status as they have for adults unless stated otherwise.

NHS England Specialised Commissioning
Drugs carrying the NHS England logo are commissioned by them. Links to key documents, national programmes of care, and clinical reference groups are found below.

NHSE NHS England Specialised Commissioning: Key documents

NHSE NHS England Specialised Commissioning: National programmes of care and clinical reference groups

 Useful Links

09.01 Anaemias and some other blood disorders
09.01.01 Iron-deficiency anaemias Oral iron
Compound iron preparations Parenteral iron
09.01.02 Drugs used in megaloblastic anaemias
09.01.03 Drugs used in hypoplastic, haemolytic, and renal anaemias
Iron overload
09.01.04 Drugs used in platelet disorders
09.01.05 G6PD deficiency
09.01.06 Drugs used in neutropenia
09.01.07 Drugs used to mobilise stem cells
09.02 Fluids and electrolytes
09.02.01 Oral preparations for fluid and electrolyte imbalance Oral potassium
Potassium removal Oral sodium and water
Oral rehydration therapy (ORT) Oral bicarbonate
09.02.02 Parenteral preparations for fluid and electrolyte imbalance Electrolytes and water
Intravenous sodium
Intravenous glucose
Intravenous potassium
Bicarbonate and lactate
Water Plasma and plasma substitutes
Plasma substitutes
09.03 Intravenous nutrition
Supplementary preparations
09.04 Oral nutrition
09.04.01 Foods for special diets
09.04.02 Enteral nutrition
09.05 Minerals
09.05.01 Calcium and magnesium Calcium supplements Hypercalcaemia and hypercalciuria Magnesium
09.05.02 Phosphorus Phosphate supplements Phosphate-binding agents
09.05.03 Fluoride
09.05.04 Zinc
09.05.05 Selenium and copper
09.06 Vitamins
09.06.01 Vitamin A
09.06.02 Vitamin B group
Oral vitamin B complex preparations
Other compounds
09.06.03 Vitamin C
09.06.04 Vitamin D
Vitamin D with Calcium
09.06.05 Vitamin E
09.06.06 Vitamin K
09.06.07 Multivitamin preparations
Vitamin and mineral supplements and adjuncts to synthetic diets
09.07 Bitters and tonics
09.08 Metabolic disorders
09.08.01 Drugs used in metabolic disorders
Wilsons disease
Carnitine deficiency
Fabry's disease
Gaucher's disease
Mucopolysaccharidosis I
Pompe disease
Nephropathic cystinosis
Urea cycle disorders
09.08.02 Acute porphyrias
Drugs unsafe for use in acute porphyrias